Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2K Buy
104
+14
+16% +$2.98K ﹤0.01% 731
2026
Q1
$18K Buy
90
+50
+125% +$10.8K ﹤0.01% 828
2025
Q4
$9.16K Sell
40
-10
-20% -$2.09K ﹤0.01% 808
2025
Q3
$8.05K Sell
50
-32
-39% -$5.06K ﹤0.01% 834
2025
Q2
$13.9K Buy
82
+34
+71% +$5.3K ﹤0.01% 756
2025
Q1
$6.79K Buy
48
+43
+860% +$6.91K ﹤0.01% 860
2024
Q4
$792 Hold
5
﹤0.01% 1132
2024
Q3
$635 Hold
5
﹤0.01% 1141
2024
Q2
$541 Buy
+5
New +$508 ﹤0.01% 1171
2023
Q3
Sell
-5
Closed -$243 704
2023
Q2
$243 Hold
5
﹤0.01% 1000
2023
Q1
$278 Hold
5
﹤0.01% 966
2022
Q4
$201 Buy
+5
New +$206 ﹤0.01% 935

Other funds holding NTRA

CVA Family Office's NTRA Position: Q2 2026 in Review

CVA Family Office increased its Natera (NTRA) stake by 16% in Q2 2026, buying an estimated $2.98K and bringing the position to 104 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

CVA Family Office first reported a position in NTRA in Q4 2022 and has held it in 12 quarters since. 844 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • CVA Family Office held 104 shares of Natera worth $28.2K as of Q2 2026.
  • CVA Family Office bought 14 Natera shares in Q2 2026, an estimated $2.98K.
  • Natera made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #731 holding.
  • CVA Family Office first reported a position in Natera in Q4 2022 and has held it in 12 quarters since.
  • 844 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.